SLC35C1 and neoplasm: We used the Cellminer database to study the correlation between the SLC35C1 gene and anti-tumor drugs, and found that the high expression of the gene SLC35C1 was predicted to be related to resistance to multiple anti-tumor drugs (Fig. 8C).